PWC ICAP 7.1.24

Doctor using tablet
Generative AI (GenAI) can transform healthcare in ways that weren’t possible before.

Seventy-six percent of health services executives consider AI and GenAI as priority investments for the next 12 months, according to PwC’s latest emerging technology survey.

More than half of the health services executives PwC surveyed are already using GenAI in some areas of their business, looking to change clinical operations and reinvent the business model with better member, patient and provider experiences, greater productivity and lower administrative costs.

PwC is invested in helping companies build scalable capabilities and operating models to harness the potential of GenAI and differentiate themselves.

Download the article below to discover how payers and providers are leveraging AI across the value chain.

Name*

First NameLast Name

Organization Name*

Title*

Country*

State*

E-mail Address*

example@example.com

utm_source

utm_medium

utm_campaign

By clicking below, you consent to receive emails from us related to this content; and for us to share your contact information with the content sponsor who may contact you, by email or otherwise, about their related products and services. You may unsubscribe or change your email preferences through links in emails you receive. For more information, see Modern Healthcare’s Privacy Policy.

How GenAI is already reshaping the business of healthcare